Australia and the Netherlands Partner on Hydrogen Supply Chain

The governments of Australia and the Netherlands have signed a Memorandum of Understanding (MoU) to develop a renewable hydrogen supply chain stretching from Australia to Europe, via the Port of Rotterdam.

The “milestone” agreement was signed during a visit to Europe by Australia’s climate change and energy minister Chris Bowen to promote renewable energy ambition and cooperation.

Australia has an abundance of renewable energy – including solar and wind – giving it a natural advantage for extracting hydrogen from water for domestic and international supply. Its government has invested more than $525 million in hydrogen hubs across the country to date.

“Hydrogen is a critical technology for the changing global economy and working with countries like the Netherlands will help Australia realize job and investment opportunities of this new industry, and deliver energy security and emissions reductions for trading partners,” said Bowen. “With considerable renewable energy resources, Australia is in a strong position to export renewable energy, develop clean energy supply chains, and attract foreign investment.

The MoU covers various aspects, including hydrogen trade policy, standards and certification schemes, port infrastructure, hydrogen technologies and regulations, among others.

© Shutterstock/ audio und werbung
© Shutterstock/ audio und werbung

The MoU complements other agreements that Rotterdam has with a number of Australian states, including Tasmania, Queensland, Western Australia and South Australia, to establish a large-scale hydrogen network between the two countries, potentially making the Dutch port an international hub for hydrogen imports, including for transport to other Northwest European countries.

The Port of Rotterdam is also involved in the HySupply feasibility study, which is exploring the possibilities and conditions for Australia to supply green hydrogen to Germany. The two-year study was expected to conclude last December.

Author: Elaine Burridge, Freelance Journalist

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.